# A Study of RAY1225 at Different Injection Sites in Participants With Different Body Sizes

> **NCT06577428** · PHASE1 · COMPLETED · sponsor: **Guangdong Raynovent Biotech Co., Ltd** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** RAY1225

## Key facts

- **NCT ID:** NCT06577428
- **Lead sponsor:** Guangdong Raynovent Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-30
- **Primary completion:** 2024-09-29
- **Final completion:** 2024-10-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06577428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06577428, "A Study of RAY1225 at Different Injection Sites in Participants With Different Body Sizes". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06577428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*